Composite gel, preparation method and application
A composite gel combining polylactic acid, hyaluronic acid, and inorganic materials like hydroxyapatite addresses inflammation issues in polylactic acid products by enhancing biocompatibility and mechanical strength, providing effective tissue filling and repair with integrated benefits.
Patent Information
- Application Number
- JP2024532325
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-29
- Filing Date
- 2022-11-09
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2042-11-09
AI Technical Summary
Polylactic acid-based injectable products cause sterile inflammation due to slow lactic acid metabolism and acidity accumulation, necessitating an alkaline neutralizing agent like hydroxyapatite to mitigate inflammation and improve biocompatibility.
A composite gel is formed by crosslinking polylactic acid and hyaluronic acid with inorganic materials such as hydroxyapatite, calcium carbonate, or calcium tartrate, using chemical or physical crosslinking methods to enhance biocompatibility and mechanical strength, and integrate the benefits of collagen regeneration and lactic acid neutralization.
The composite gel provides a stable, biocompatible, and mechanically strong material for tissue filling and repair, with improved hydrophilicity and thermal stability, offering instant filling and collagen regeneration effects while reducing inflammation.
Smart Images

Figure 2024542665000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to the technical field of biomedical materials, in particular to a composite gel, its preparation method and application. [Background technology]
[0002] Polylactic acid (PLA), also known as polylactide, is a polyester polymer obtained by polymerizing lactic acid as the main raw material. Due to its characteristics of good biocompatibility, biodegradability, and ease of processing, it is used to bond with hydroxyapatite to improve its mechanical and biological properties.
[0003] At present, regenerative injection products have been widely accepted around the world, and polylactic acid serves as the main material for regenerative injection products. When polylactic acid enters human skin, it can stimulate the regeneration of the body's own tissue. Through the regeneration of the body's own tissue, it plays the role of structural reconstruction and volume filling, and achieves the purpose of anti-aging. The main types of tissue that can be regenerated after stimulation are fibroblasts and collagen. In be.
[0004] Polylactic acid stimulates the body's own fibroblasts to secrete collagen, making the filling and repair effect more natural, while at the same time enhancing the skin's luster and achieving overall facial rejuvenation. However, the natural disadvantage of polylactic acid is that it decomposes in the body to produce lactic acid, but the metabolism of lactic acid in the body is slow, and the accumulation of a large amount of lactic acid is prone to cause sterile inflammation, resulting in a series of adverse reactions.
[0005] Therefore, when polylactic acid is used, it is necessary to add an alkali neutralizer to reduce aseptic inflammation caused by local excessive acidity. Hydroxyapatite, which is alkaline and has good biocompatibility, is the most suitable as an alkali neutralizer for polylactic acid.
[0006] Composite materials formed by polylactic acid and inorganic materials have been used in biomaterials, for example, CN106139256A discloses polylactic acid / nano β-tricalcium phosphate composite porous scaffolds, and CN111905151A discloses mesoporous bioactive glass / polylactic acid-co-glycolic acid composite microspheres.
[0007] In particular, composite materials of hydroxyapatite and polylactic acid are widely used in the orthopedic field. Hwang Ji-hwan et al. (Journal of Composite Materials Science, 2021, 38:749-760) studied nano-HAP poly-L-lactic acid (PLLA) composite materials and found that the compressive yield strength and tensile strength of PLLA with added HAP were 9.4% and 6.6% higher than those of pure PLLA materials, respectively, and the initial decomposition temperature was 1.2 times higher than that of pure PLLA materials. 7 .4 % high It can be seen that the degree of crystallinity increases by 6.7%.
[0008] As can be seen, the PLLA material with added HAP has obvious advantages over the pure PLLA material in terms of material properties. Hydroxyapatite can also reduce inflammation: compared with the PLA material with increased HAP, the pure PLA has a stronger inflammatory response, while the HAP-PLA composite material only shows a very mild inflammatory response in the body. It can be proven that the addition of HAP can neutralize the acidic substances caused by the decomposition of PLA and reduce the sterile inflammation caused by acidity.
[0009] At present, binary composites of hydroxyapatite and polylactic acid, and ternary composites or composite microspheres of hydroxyapatite, polylactic acid, and other polymers have been reported in China and abroad. Dong Yan et al. (Additive Manufacturing, 2020; 34: 101305) have prepared microspheres blended with polylactic acid and nanoscale hydroxyapatite, the minimum particle size of which is about 100 μm, and are mainly used in research on microcarriers, etc.
[0010] For example, preparation method of nano-hydroxyapatite / polylactic acid composite microspheres (CN101590388A), hydroxyapatite-loaded polylactic acid porous microspheres and preparation method (CN103868658B), polylactic acid / hydroxyapatite crystal whisker composite porous scaffold for bone tissue and preparation method (CN105797215A), polylactic acid-hydroxyapatite micron-nano multi-level structure composite microsphere material and application (CN1097491 Patents such as "CN107519536A", "Preparation Method for Hydroxyapatite / Modified Polylactic Acid Composite Microspheres" (CN109350768A), and "Preparation Method for Hydroxyapatite / Polylactic Acid / Chitosan Composite Microspheres" (CN102489231B) are mainly used for bone defect repair, filling and drug carrying properties, but not in the field of tissue filling. Summary of the Invention
[0011] The present invention provides a composite gel, preparation method and application thereof, which integrates the advantages of three materials, namely hyaluronic acid, polylactic acid and inorganic material, and can be used for filling and repairing biological tissue.
[0012] The technical solutions provided by the present invention are as follows:
[0013] A composite gel ,two The biphasic microspheres are prepared by crosslinking polylactic acid / inorganic material biphasic microspheres with hyaluronic acid.
[0014] Further, the inorganic material is one or more selected from calcium carbonate, calcium phosphate, and calcium tartrate; further, the calcium phosphate is preferably hydroxyapatite; and further, the inorganic material is a nano-inorganic material.
[0015] In one embodiment, the inorganic material is nano-calcium hydroxyapatite.
[0016] Further, the hyaluronic acid is crosslinked hyaluronic acid; further, the crosslinked hyaluronic acid is prepared by a crosslinking agent, the crosslinking agent being one or more selected from dialdehydes, disulfides, polyethylene glycol (PEG) crosslinkers, divinyl sulfones, diglycidyl ethers, diepoxides, diamines and polyamines.
[0017] Furthermore, the crosslinking agent may be selected from the group consisting of biscarbodiimides, fatty diamines, ethylenediamine, hexamethylenediamine, endogenous polyamines (spermine or spermidine), pentaerythritol tetraglycidyl ether (PETGE), diethylenesulfone (DVS), 1,4-butanediol diglycidyl ether (BDDE), 1,2-bis(2,3-epoxypropoxy)ethylene (EGDGE), 1,2,7,8-diepoxyoctane (DEO), (phenylene bis-(ethyl)-carbodiimide and 1,6-hexamethylene bis(ethyl) carbodiimide), adipic dihydrazide (ADH), bis(sulfosuccinimide) suberic acid ester (BS), hexamethylenediamine (HMDA), 1-(2,3-epoxypropyl)-2,3-epoxycyclohexane, 1,4-bis(2,3-epoxypropoxy)butane, 1,4-bisglycidyl ether oxybutane, 1-(2,3-epoxypropyl)-2,3-epoxycyclohexane, 1,3-butadiene diepoxide, 1,2,7,8-diepoxyoctane, 1,5-hexadiene diepoxide.
[0018] Preferably, the crosslinking agent is a diamine or polyamine, and its reaction process can be referred to patents such as CN99813143.1, US9907739, CN202111326226.7.
[0019] Additionally, the crosslinking includes crosslinking between polylactic acid and hyaluronic acid in the biphasic microspheres.
[0020] Furthermore, the crosslinking between the polylactic acid and the hyaluronic acid includes any one of physical electrostatic crosslinking and chemical crosslinking. The chemical crosslinking includes reacting the polylactic acid in the two-phase microsphere with the hyaluronic acid to form an amide bond crosslinking reaction. The physical electrostatic crosslinking includes forming electrostatic crosslinks with the hyaluronic acid after performing surface charge modification on the two-phase microsphere.
[0021] Furthermore, the chemical crosslinking includes amino-modifying polylactic acid in the two-phase microspheres and then reacting it with hyaluronic acid to form an amide bond crosslinking reaction, and the physical electrostatic crosslinking includes surface charge modification of the two-phase microspheres and then forming electrostatic crosslinks with crosslinked hyaluronic acid having cations.
[0022] In one embodiment, a composite gel is provided, which is obtained by crosslinking hydroxyapatite-dispersed polylactic acid biphasic microspheres composed of polylactic acid and nanoscale hydroxyapatite with hyaluronic acid.
[0023] A method for preparing a composite gel, comprising the step of crosslinking two-phase microspheres with hyaluronic acid to form a composite gel (three-phase composite gel), wherein the two-phase microspheres are polylactic acid / inorganic two-phase microspheres.
[0024] Furthermore, cross-linking the biphasic microspheres with hyaluronic acid includes cross-linking the polylactic acid and hyaluronic acid in the biphasic microspheres.
[0025] Furthermore, the hyaluronic acid is non-crosslinked hyaluronic acid or crosslinked hyaluronic acid. In one embodiment, the hyaluronic acid is crosslinked hyaluronic acid, preferably diamine crosslinked hyaluronic acid or polyamine crosslinked hyaluronic acid, more preferably endogenous polyamine crosslinked hyaluronic acid.
[0026] In one embodiment, in the hydroxyapatite-dispersed polylactic acid two-phase microspheres, the mass of hydroxyapatite accounts for 0.1 to 50% of the total mass of the microspheres, and the remaining portion of the microspheres other than hydroxyapatite is entirely polylactic acid.
[0027] In one embodiment, a polyamine is used as a crosslinker to prepare a crosslinked hyaluronic acid hydrogel, preferably the polyamine crosslinker accounts for 0.5-20% of the total mass of the hyaluronic acid, and the mass concentration range of hyaluronic acid in said hydrogel is 1-35 mg / mL.
[0028] In one embodiment, the hyaluronic acid is prepared by microbial fermentation. Obtained Preferably, the molecular weight range of the hyaluronic acid is 100 KDa to 3 , 000KDa, preferably 500KDa to 1 , The molecular weight of hyaluronic acid fermented by microorganisms is 500KDa. Hyaluronic acid fermented by microorganisms is a non-animal derived hyaluronic acid and has a more uniform molecular weight distribution.
[0029] In one embodiment, the bridges are solid-phase bridges; further, the solid-phase bridges include any one of physical electrostatic bridges and chemical crosslinks.
[0030] In one embodiment, the chemical crosslinking comprises amino-modifying the polylactic acid in the biphasic microspheres and then reacting the modified biphasic microspheres with hyaluronic acid to form amide bond crosslinks; the amino-modification further comprises reacting the biphasic microspheres with an amine compound; and the amide bond crosslinking further comprises coupling the modified biphasic microspheres with hyaluronic acid in the presence of a carbodiimide activator.
[0031] In one embodiment, the amine compound includes a diamine, a polyamine, or a polyamino compound.Preferably, the diamine includes any one of an aliphatic diamine, an aromatic diamine, and a heteroatom diamine, such as, but not limited to, an aliphatic diamine, an ethylenediamine, and a hexamethylenediamine; the polyamine includes any one of an aliphatic polyamine, an aromatic polyamine, and a heteroatom polyamine, such as, but not limited to, an endogenous polyamine such as spermidine or spermine; the polyamino compound includes any one of a double-end aminated polyethylene glycol and a terminally aminated multi-arm polyethylene glycol; Further, the carbodiimide activator includes one or more of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), 1-(3-dimethylaminopropyl)-3-ethyl-carbodiimide, 1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide, 1,3-bis[di(methoxymethyl)methyl]carbodiimide, or a salt thereof.
[0032] In one embodiment, the preparation method further comprises using the carbodiimide activator together with an auxiliary agent, such as N-hydroxysuccinimide (NHS), tert-butyl alcohol, etc. In order to improve the crosslinking reaction efficiency, the water-soluble carbodiimide activator needs to be used together with an auxiliary agent, and the amount of the auxiliary agent added is 10-30% of the mass of the carbodiimide.
[0033] In one embodiment, the mass ratio of the biphasic microspheres to the hyaluronic acid in the chemical crosslinking is 1:0.5-20, preferably 1:1-10; Amino modification In the reaction system, the amount of the amine compound added is 30 to 200% of the mass of the two-phase microspheres; the concentration range of the amine compound is 10 to 1000 mg / mL; Furthermore, the amount of the carbodiimide activator added is 10 to 150% of the total mass of the hyaluronic acid; Furthermore, the concentration of the hyaluronic acid solution is 10 to 100 mg / mL; Furthermore, the temperature of the amino modification reaction and the amide bond crosslinking reaction is 5 to 60° C., the reaction time is 6 to 24 hours; the pH value of the reaction system is in the range of 5.0 to 6.0.
[0034] In one embodiment, the microspheres are hydroxyapatite-dispersed polylactic acid two-phase microspheres, and the chemical crosslinking includes the steps of dispersing the hydroxyapatite-dispersed polylactic acid two-phase microspheres in water, adding an amine compound (polyamine derivative), adjusting the pH value, and reacting the carboxyl groups on the surface of the microspheres with the polyamine derivative for surface modification to modify the amino groups on the surface; and placing the surface amino-modified hydroxyapatite-dispersed polylactic acid microspheres (PLA-HAP two-phase microspheres) in a hyaluronic acid solution, adjusting the pH value to 5.0-6.0, and simultaneously adding a carbodiimide activator and an auxiliary to complete the coupling reaction of the PLA-HAP two-phase microspheres.
[0035] The surface modification reaction temperature is 5 to 60° C., and the reaction time is 6 to 24 hours. The coupling reaction temperature is 5 to 60° C., and the reaction time is 6 to 24 hours.
[0036] The physical electrostatic crosslinking includes surface charge modification of the biphasic microspheres to obtain modified biphasic microspheres carrying anions on the surface, and mixing the modified biphasic microspheres with crosslinked hyaluronic acid having cations to generate electrostatic crosslinks; the crosslinked hyaluronic acid having cations is crosslinked hyaluronic acid obtained by crosslinking with diamine or polyamine; and the surface charge modification of the biphasic microspheres includes immersing the biphasic microspheres in an alkaline buffer solution and separating them.
[0037] Furthermore, the mass ratio of the two-phase microspheres to the crosslinked hyaluronic acid in the physical crosslinking is 1:1-50; preferably, 1:1-20; Furthermore, the alkaline buffer solution is an alkaline phosphate buffer solution; the pH range of the alkaline phosphate buffer solution is preferably 9.0 to 11.0.
[0038] In one embodiment, the microspheres are hydroxyapatite-dispersed polylactic acid biphasic microspheres, and the physical crosslinking includes immersing the hydroxyapatite-dispersed polylactic acid biphasic microspheres in a PBS solution of pH 9.0-11.0 to carry out surface charge modification, whereby the surface of the microspheres carries a negative charge, and then isolating and removing the biphasic microspheres, and physically mixing them with a crosslinked hyaluronic acid gel using polyamine as a crosslinking agent, whereby the carboxylate anions on the surface of the polylactic acid are electrostatically crosslinked with the ammonium cations of the crosslinked hyaluronic acid.
[0039] In one embodiment, the present invention further comprises a method for preparing hydroxyapatite-dispersed polylactic acid biphasic microspheres, said method comprising: (a) dissolving polylactic acid (PLA) in dichloromethane, thoroughly stirring to prepare a solution, and then filtering to remove insoluble matter; (b) adding hydroxyapatite, applying ultrasonic waves and uniformly stirring to completely disperse the hydroxyapatite in the solution and form a suspension in which the hydroxyapatite is uniformly dispersed; (c) Prepare a polyvinyl alcohol solution according to the ratio of dichloromethane and stir it. During this period, add a dichloromethane suspension dropwise to the system, and dissolve the polyvinyl alcohol in the dichloromethane solution by stirring, shearing and emulsifying. fluid particles forming a (d) placing the emulsified solution in a water bath, stirring and evaporating to remove the dichloromethane, and then washing and filtering the resulting solution.
[0040] In one specific embodiment, in step (a), preferably, the concentration of the PLA in the dichloromethane solution is 10 mg / mL to 80 mg / mL, including but not limited to 15 mg / mL, 30 mg / mL, 40 mg / mL, 60 mg / mL and 80 mg / mL.
[0041] Preferably, the PLA comprises a mixture of one or more of poly-L-lactic acid (PLLA), polyracemic lactic acid (PDLLA) and poly-D-lactic acid (PDLA).
[0042] Preferably, the molecular weight range of the PLA is 10 KDa to 150 KDa.
[0043] In one specific embodiment, in the step (b), the mass fraction of the hydroxyapatite is preferably 1% to 20%, so that it is completely incorporated into the polylactic acid microspheres. dispersion Ensure what you can.
[0044] Preferably, the ultrasonic energy is 1 to 300 KJ, and more preferably, the energy is 1 to 20 KJ, and the calculation formula for the ultrasonic energy is as follows: Ultrasonic energy (KJ) = ultrasonic power (W) x ultrasonic time (sec) / 1000.
[0045] In one specific embodiment, in step (c), the concentration of the polyvinyl alcohol solution is preferably 5 mg / m L ~30mg / m L Within this concentration range, the emulsification effect is ensured and the size of the microspheres can be controlled.
[0046] Preferably, the ratio of the dichloromethane solution to the polyvinyl alcohol solution is 1 / 2 to 1 / 10.
[0047] Preferably, the rotation speed of the stirring paddle of the stirring device is 100 to 600 rpm. m This rotational speed range can ensure continuous emulsification and form a good emulsion.
[0048] In one specific embodiment, in step (d), the water bath temperature is preferably 20-37°C, in which the evaporation rate of dichloromethane can be controlled, thereby optimizing the hollow effect and surface microporous structure of the microspheres; after step (d), the obtained filter cake is dried to obtain two-phase polylactic acid hydroxyapatite nano-dispersed microspheres; preferably, the drying process includes two methods, namely vacuum oven drying and freeze-drying, in which the boiling point of water is lowered in a near vacuum state to evaporate water at a lower temperature, and the freeze-drying method utilizes the principle of ice crystal sublimation to avoid the destruction of the internal structure of the microspheres during the liquefaction process of the solid phase components, and can better maintain the spatial structure of the obtained polylactic acid microspheres.
[0049] In one embodiment, the average elastic modulus of the composite gel of the present invention is 400 to 1000 Pa.
[0050] In one embodiment, the elastic modulus loss rate of the composite gel of the present invention before and after sterilization is less than 30%, more preferably less than 20%. In another aspect, the present invention protects the composite gel produced by the preparation method.
[0051] In a further aspect, the present invention further covers the application of the composite gel in the preparation of drug carriers, tissue fillers or tissue repair materials.
[0052] Furthermore, the drug carrier can be a biological drug, a chemical drug or a naturally extracted drug.
[0053] The beneficial effects are as follows:
[0054] (1) The present invention first prepares polylactic acid-inorganic biphasic microspheres, and then uses solid-phase crosslinking technology to carry out physical electrostatic crosslinking or chemical crosslinking between the terminal carboxyl groups of polylactic acid in the biphasic microspheres and hyaluronic acid. The three-phase composite gel thus formed has high stability and good biocompatibility and can be used for filling and repairing biological tissues.
[0055] (2) The two-phase microsphere of the present invention further improves the hydrophilicity of polylactic acid microspheres by adding hydrophilic calcium salt inorganic material (such as hydroxyapatite, calcium phosphate, calcium tartrate, etc.).And the calcium-based inorganic material in the two-phase microsphere can be introduced into the macroscopic network structure of cross-linked hyaluronic acid with micron-scale polylactic acid as a carrier (particles of cross-linked hyaluronic acid are also micron-scale), and the complex formation between calcium ion and carboxyl group and hydroxyl group in hyaluronic acid fills the network gap between cross-linked hyaluronic acid, thereby making the three-phase gel have a tighter network structure; at the same time, the complex formation between calcium-based inorganic material and hyaluronic acid shortens the distance between the molecular chains of polylactic acid and hyaluronic acid, so that the cross-linking reaction efficiency of both is improved, and the mechanical strength and thermal stability of the three-phase composite gel are improved.
[0056] (3) The preparation method of the present invention has a simple process, convenient operation, and is easy to be industrialized.
[0057] (4) The composite gel prepared by the present invention can exert the immediate filling effect of hyaluronic acid, the collagen regeneration effect of polylactic acid, and the bone filling and lactic acid neutralization effects of calcium-based inorganic materials such as hydroxyapatite, thereby integrating the advantages of three materials.
[0058] In order to more clearly describe the specific embodiments of the present invention or the technical solutions of the prior art, the following briefly introduces drawings required for the description of the specific embodiments or the prior art. Obviously, the drawings in the following description are some embodiments of the present invention, and those skilled in the art can obtain other drawings based on these drawings without creative work. [Brief description of the drawings]
[0059] [Figure 1] 1 is a micrograph of the biphasic polylactic acid hydroxyapatite nano-dispersed microspheres in Example 1 of the present invention. [Diagram 2] 1 is a scanning electron microscope photograph of the biphasic polylactic acid hydroxyapatite nano-dispersed microspheres in Example 1 of the present invention. [Diagram 3] 1 is a locally enlarged scanning electron microscope photograph of two-phase polylactic acid hydroxyapatite nano-dispersed microspheres in Example 1 of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0060] The following embodiments are provided to clearly and completely describe the technical solutions of the present invention, and it is obvious that the described embodiments are only some, but not all, of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative work fall within the scope of protection of the present invention.
[0061] Example 1 Example 1. Preparation of Two-Phase Microspheres 1 Weigh out 1.8g of polylactic acid and put it into a 50mL beaker, then add 50mL of dichloromethane and stir with a spoon until it is completely dissolved, then filter it into an ultrasonic beaker using a 10mm nylon 66 material syringe filter, then weigh out 0.2g of nano-hydroxyapatite and add it to the system, and adjust the output to 60%. (12KJ) The nanomaterials were then allowed to react for 10 min at 400°C for 10 min to completely disperse the nanomaterials in the dichloromethane solution of polylactic acid. During this period, 135 mL of polyvinyl alcohol solution (1.5 wt%) was added to a 300 mL three-neck flask and placed in a water bath at 30°C, followed by 400 rp m After the ultrasonic waves are terminated, the dichloromethane suspension is stirred mechanically at 100°C. Polyvinyl alcohol Slowly add to the solution and stir overnight while dichloromethane is removed by evaporation.
[0062] The turbid liquid obtained in the previous step is diluted to 500 mL with purified water, left to stand for 1 hour, and the upper suspension is discarded, which is repeated twice, and then the precipitate is redissolved and filtered through a 0.45 μm aqueous filtration membrane to remove the liquid, and then the obtained solid is dispersed in 200 mL of purified water and filtered again, which is repeated four times, and then the obtained solid is redissolved in 150 mL of purified water, placed in a Schott bottle, heated in an oven at 100 ° C for 30 minutes, removed, cooled, filtered, washed three times with purified water, and the solid obtained in the last wash is transferred to a culture dish and dried overnight at 40 ° C in a vacuum drying oven to obtain the final product. The particle size of the product is mainly distributed in the range of 25 to 86 μm, and the micrograph is shown in FIG. 1, and the scanning electron micrograph is shown in FIG. 2 to 3. As can be seen from the figures, the two-phase microspheres have a regular morphology and uniform particle size.
[0063] Example 2 Example 2. Preparation of biphasic microspheres 2 Weigh out 1.6g of polylactic acid and put it into a 50mL beaker, then add 50mL of dichloromethane and stir with a spoon until it is completely dissolved, then filter it into an ultrasonic beaker using a 10mm nylon 66 material syringe filter, then weigh out 0.2g of nano-hydroxyapatite and add it to the system, and adjust the output to 60%. (12KJ) The nanomaterials were then allowed to react for 10 min at 400°C for 10 min to completely disperse the nanomaterials in the dichloromethane solution of polylactic acid. During this period, 90 mL of polyvinyl alcohol solution (1.5 wt%) was added to a 300 mL three-neck flask and placed in a water bath at 30°C, followed by 400 rp m After the ultrasonic waves are terminated, the dichloromethane suspension is stirred mechanically at 100°C. Polyvinyl alcohol Slowly add to the solution and stir overnight while dichloromethane is removed by evaporation.
[0064] The turbid liquid obtained in the previous step is diluted to 500mL with purified water, left to stand for 1 hour, the upper suspension is discarded, this is repeated twice, the precipitate is redissolved, filtered through a 0.45μm aqueous filtration membrane to remove the liquid, the resulting solid is dispersed in 200mL of purified water, filtered again, this is repeated four times, the resulting solid is redissolved in 150mL of purified water, placed in a shot bottle, heated in a 100℃ oven for 30 minutes, removed, cooled, filtered, washed three times with purified water, the solid obtained in the last wash is transferred to a culture dish and freeze-dried to obtain the final product. The particle size is mainly distributed in the range of 25-72μm.
[0065] Example 3 Example 3. Physical cross-linking of three-phase gels Weigh out 1.5g of sodium hyaluronate (molecular weight 900KDa), then add 37.5mL of purified water, and after complete dissolution, the hyaluronic acid concentration is 40mg / mL, and 45mg of spermidine is added to the hyaluronic acid solution. On the premise of three-site crosslinking of spermidine, adjust the pH value of the hyaluronic acid solution to about 6.2 using 6mol / L hydrochloric acid solution, and Post-stirring Stir, add 0.214 g of EDC, and simultaneously add 0.04 g of NHS. Continue stirring uniformly, seal, and place in a 40° C. blower drying oven to react for 14 hours.
[0066] After the reaction was completed, 40 mL of anhydrous ethanol was added, and the mixture was ground using an IKAT25 high shear disperser at a grinding speed of 10,000 rp. m Continue grinding the gel particles for 5 minutes. After grinding is completed, continue adding 200mL of absolute ethanol to completely dehydrate the gel. Separate the precipitate, wash the precipitate with 200mL of absolute ethanol five times in succession, then place in a vacuum oven, and then vacuum dry at a vacuum degree of -0.09MPa and 40℃ for 24 hours. After complete drying, take 1.0g of dried gel, add a total of 50mL of PBS with a concentration of 10mg / mL and pH 6.0, and wait until the gel is completely swollen before preparing it for use.
[0067] Take 3.0g of the two-phase microsphere obtained in Example 1, immerse in 50mL of pH 9.0 PBS solution to carry out surface charge modification, so that the surface of the microsphere carries negative charge, and after immersion for 30 minutes, separate and take out the two-phase microsphere, drain and then physically mix with 50mL of cross-linked hyaluronic acid gel, so that electrostatic cross-linking occurs between the carboxylate anion on the surface of polylactic acid and the ammonium cation of cross-linked hyaluronic acid.After uniform mixing, fill the three-phase gel into a pre-filled syringe, and sterilize with moist heat at 121℃ for 15 minutes to obtain the final gel product.
[0068] Example 4 Example 4. Chemical cross-linking of three-phase gels Take 1.5 g of the two-phase microspheres obtained in Example 1, add 100 mL of purified water, add 2.0 g of ethylenediamine, adjust the pH of the solution to 5.5 using 1 mol / L hydrochloric acid solution, add 2.0 g of EDC and 0.4 g of NHS for surface amino modification reaction, and react at 40 ° C for 16 hours. Filter and separate the microspheres, wash the microspheres with purified water to a pH range of 7.0-7.1, and dry in a vacuum drying oven at 40 ° C overnight to obtain surface amino modified two-phase microspheres.
[0069] 1.5g of sodium hyaluronate was weighed out, then 37.5mL of purified water was added and completely dissolved. The concentration of hyaluronic acid at this time was 40mg / mL. The hyaluronic acid solution contained ,in Obtained Surface Amino Modification Add 1.0 g of biphasic microspheres. Adjust the pH value of the hyaluronic acid solution to about 5.5 using 0.1 mol / L hydrochloric acid solution. Post-stirring Stir, add 0.3g of EDC, and simultaneously add 0.06g of NHS (20% of the mass of EDC), continue to stir evenly, seal, and react in a 40°C blow dry oven for 14 hours.
[0070] After the reaction is completed, 200mL of anhydrous ethanol is added to completely dehydrate the gel. The precipitate is separated and washed five times in succession with 200mL of anhydrous ethanol, then placed in a vacuum oven and vacuum dried at a vacuum degree of -0.09MPa and 40℃ for 24 hours. After complete drying, 1.0g of dried gel is taken and a total of 50mL of phosphate buffer solution with a concentration of 10mg / mL and a pH of 7.0 is added. After the gel is completely swollen, the gel is filled into a prefilled syringe and sterilized with wet heat at 121℃ for 15 minutes to obtain the final product, a three-phase gel.
[0071] Example 5 Example 5. Preparation of calcium carbonate biphasic microspheres Weigh out 1.6g of polylactic acid and put it into a 50mL beaker, then add 50mL of dichloromethane and stir with a spoon until it is completely dissolved, then filter it into an ultrasonic beaker using a 10mm nylon 66 material syringe filter, then weigh out 0.2g of nano calcium carbonate and add it to the system, and adjust the output to 60%. (12KJ) The nanomaterials were then allowed to react for 10 min at 400°C for 10 min to completely disperse the nanomaterials in the dichloromethane solution of polylactic acid. During this period, 90 mL of polyvinyl alcohol solution (1.5 wt%) was added to a 300 mL three-neck flask and placed in a water bath at 30°C, followed by 400 rp m After the ultrasonic waves are terminated, the dichloromethane suspension is stirred mechanically at 100°C. Polyvinyl alcohol Slowly add to the solution and stir overnight while dichloromethane is removed by evaporation.
[0072] The turbid liquid obtained in the previous step is diluted to 500mL with purified water, left to stand for 1 hour, and the upper suspension layer is discarded, which is repeated twice; then the precipitate is redissolved and filtered through a 0.45μm aqueous filtration membrane to remove the liquid; then the obtained solid is dispersed in 200mL of purified water and filtered again, which is repeated four times; then the obtained solid is redissolved in 150mL of purified water, placed in a shot bottle, heated in an oven at 100℃ for 30 minutes, removed, cooled, filtered, washed with purified water three times, and the solid obtained from the last wash is transferred to a culture dish and freeze-dried to obtain the final product.
[0073] Example 6 Example 6. Preparation of calcium tartrate biphasic microspheres Weigh out 1.6g of polylactic acid and put it into a 50mL beaker, then add 50mL of dichloromethane and stir with a spoon until it is completely dissolved, then filter it into an ultrasonic beaker using a 10mm nylon 66 material syringe filter, then weigh out 0.2g of nano calcium tartrate and add it to the system, and adjust the output to 60%. (12KJ) The nanomaterials were then allowed to react for 10 min at 400°C for 10 min to completely disperse the nanomaterials in the dichloromethane solution of polylactic acid. During this period, 90 mL of polyvinyl alcohol solution (1.5 wt%) was added to a 300 mL three-neck flask and placed in a water bath at 30°C, followed by 400 rp m After the ultrasonic waves are terminated, the dichloromethane suspension is stirred mechanically at 100°C. Polyvinyl alcohol Slowly add to the solution and stir overnight while dichloromethane is removed by evaporation.
[0074] The turbid liquid obtained in the previous step is diluted to 500mL with purified water, left to stand for 1 hour, and the upper suspension layer is discarded, which is repeated twice; then the precipitate is redissolved and filtered through a 0.45μm aqueous filtration membrane to remove the liquid; then the obtained solid is dispersed in 200mL of purified water and filtered again, which is repeated four times; then the obtained solid is redissolved in 150mL of purified water, placed in a shot bottle, heated in an oven at 100℃ for 30 minutes, removed, cooled, filtered, washed with purified water three times, and the solid obtained from the last wash is transferred to a culture dish and freeze-dried to obtain the final product.
[0075] Example 7 Example 7. Chemical cross-linking of calcium carbonate three-phase gel Take 1.5 g of the two-phase microspheres obtained in Example 5, add 100 mL of purified water, add 2.0 g of ethylenediamine, adjust the pH of the solution to 5.5 using 1 mol / L hydrochloric acid solution, add 2.0 g of EDC and 0.4 g of NHS for surface amino modification reaction, and react at 40 ° C for 16 hours. Filter and separate the microspheres, wash the microspheres with purified water to a pH range of 7.0-7.1, and dry in a vacuum drying oven at 40 ° C overnight to obtain surface amino modified two-phase microspheres.
[0076] 1.5g of sodium hyaluronate was weighed out, then 37.5mL of purified water was added and completely dissolved. The hyaluronic acid concentration at this time was 40mg / mL. The hyaluronic acid solution contained 1.0g of Surface Amino Modification Add the biphasic microspheres. Adjust the pH value of the hyaluronic acid solution to about 5.5 using 0.1 mol / L hydrochloric acid solution. Post-stirring Stir, add 0.3g of EDC, and simultaneously add 0.06g of NHS (20% of the mass of EDC), continue to stir evenly, seal, and react in a 40°C blow dry oven for 14 hours.
[0077] After the reaction is completed, 200mL of anhydrous ethanol is added to completely dehydrate the gel. The precipitate is separated and washed five times in succession with 200mL of anhydrous ethanol, then placed in a vacuum oven and vacuum dried at a vacuum degree of -0.09MPa and 40℃ for 24 hours. After complete drying, 1.0g of dried gel is taken and a total of 50mL of phosphate buffer solution with a concentration of 10mg / mL and a pH of 7.0 is added. After the gel is completely swollen, the gel is filled into a prefilled syringe and sterilized with wet heat at 121℃ for 15 minutes to obtain the final product, a three-phase gel.
[0078] Example 8 Example 8. Chemical cross-linking of calcium tartrate triphasic gels Take 1.5 g of the two-phase microspheres obtained in Example 6, add 100 mL of purified water, add 2.0 g of ethylenediamine, adjust the pH of the solution to 5.5 using 1 mol / L hydrochloric acid solution, add 2.0 g of EDC and 0.4 g of NHS for surface amino modification reaction, and react at 40 ° C for 16 hours. Filter and separate the microspheres, wash the microspheres with purified water to a pH range of 7.0-7.1, and dry in a vacuum drying oven at 40 ° C overnight to obtain surface amino modified two-phase microspheres.
[0079] 1.5g of sodium hyaluronate was weighed out, then 37.5mL of purified water was added and completely dissolved. The hyaluronic acid concentration at this time was 40mg / mL. The hyaluronic acid solution contained 1.0g of Surface Amino Modification Add the biphasic microspheres. Adjust the pH value of the hyaluronic acid solution to about 5.5 using 0.1 mol / L hydrochloric acid solution. Post-stirring Stir, add 0.3g of EDC, and simultaneously add 0.06g of NHS (20% of the mass of EDC), continue to stir evenly, seal, and react in a 40°C blow dry oven for 14 hours.
[0080] After the reaction is completed, 200mL of anhydrous ethanol is added to completely dehydrate the gel. The precipitate is separated and washed five times in succession with 200mL of anhydrous ethanol, then placed in a vacuum oven and vacuum dried at a vacuum degree of -0.09MPa and 40℃ for 24 hours. After complete drying, 1.0g of dried gel is taken and a total of 50mL of phosphate buffer solution with a concentration of 10mg / mL and a pH of 7.0 is added. After the gel is completely swollen, the gel is filled into a prefilled syringe and sterilized with wet heat at 121℃ for 15 minutes to obtain the final product, a three-phase gel.
[0081] Comparative Example 1 Comparative Example 1, Preparation of Non-Crosslinked Three-Phase Gel Weigh out 1.5g sodium hyaluronate, then add 37.5mL purified water, and after completely dissolving, the hyaluronic acid concentration is 40mg / mL. Add 1.0g of the two-phase microsphere obtained in Example 2 to the hyaluronic acid solution, and stir evenly. After stirring is completed, add 200mL of absolute ethanol to completely dehydrate the gel.
[0082] The precipitate is separated, washed five times with 200mL of anhydrous ethanol, and then placed in a vacuum oven and vacuum dried for 24 hours at a vacuum degree of -0.09MPa and 40°C. After complete drying, 1.0g of dried gel is taken, and a total of 50mL of phosphate buffer solution with a concentration of 10mg / mL and a pH of 7.0 is added. After the gel is completely swollen, the gel is filled into a prefilled syringe and sterilized with wet heat at 121°C for 15 minutes to obtain a non-crosslinked three-phase gel.
[0083] Comparative Example 2 Comparative Example 2: Preparation of Three-Phase Non-Physically Crosslinked Blend Gel The preparation method of spermidine cross-linked hyaluronic acid gel is the same as that in Example 3, and the overall preparation method is exactly the same.
[0084] Take 3.0g of the two-phase microspheres obtained in Example 1 and directly physically mix them with 50mL of cross-linked hyaluronic acid gel. After uniform mixing, fill the three-phase gel into a pre-filled syringe and sterilize with moist heat at 121°C for 15 minutes to obtain the final gel product.
[0085] Comparative Example 3 Comparative Example 3: Preparation of physical blend gels of single-phase PLA microspheres and cross-linked hyaluronic acid 1.6g of polylactic acid was weighed and placed in a 50mL beaker, then 50mL of dichloromethane was added and stirred with a spoon until it was completely dissolved, then filtered into an ultrasonic beaker using a 10mm nylon 66 material syringe filter, during which 90mL of polyvinyl alcohol solution (1.5wt%) was added into a 300mL three-neck flask, placed in a 30℃ water bath, and then heated to 400rpm. m Stir mechanically at speed.
[0086] Then, the dichloromethane solution Polyvinyl alcohol Slowly add to the solution and stir overnight while dichloromethane is removed by evaporation.
[0087] The turbid liquid obtained in the previous step is diluted to 500mL with purified water, left to stand for 1 hour, and the upper suspension layer is discarded, which is repeated twice; then the precipitate is redissolved and filtered through a 0.45μm aqueous filtration membrane to remove the liquid; then the obtained solid is dispersed in 200mL of purified water and filtered again, which is repeated four times; then the obtained solid is redissolved in 150mL of purified water, placed in a shot bottle, heated in an oven at 100℃ for 30 minutes, removed, cooled, filtered, and washed with purified water three times; the solid obtained from the last wash is transferred to a culture dish and freeze-dried to obtain the final product PLA microspheres.
[0088] Take 3.0g of the obtained PLA microspheres and immerse in 50mL of pH 9.0 PBS solution to carry out surface charge modification, so that the surface of the microspheres carries negative charge, and after immersion for 30 minutes, separate and take out the microspheres, drain them, and then physically mix with 50mL of the cross-linked hyaluronic acid gel obtained in Example 3, so that electrostatic cross-linking occurs between the carboxylate anion on the surface of polylactic acid and the ammonium cation of cross-linked hyaluronic acid. After uniform mixing, fill the blended gel into a pre-filled syringe and sterilize with moist heat at 121℃ for 15 minutes to obtain the final gel product.
[0089] Comparative Example 4 Comparative Example 4: Preparation of a physical blend gel of nanoscale HAP and cross-linked hyaluronic acid The preparation method of spermidine cross-linked hyaluronic acid gel is the same as that in Example 3, and the overall preparation method is exactly the same.
[0090] Take 3.0 g of nanoscale HAP and directly physically mix them with 50 mL of cross-linked hyaluronic acid gel. After uniform mixing, the blended gel is loaded into a pre-filled syringe and sterilized by moist heat at 121°C for 15 minutes to obtain the final product gel.
[0091] (Example of effect) composite Rheological property testing of gels The results obtained in the examples and comparative examples composite The gel was divided into two groups, one before sterilization and one after sterilization, and 2.0 mL of each was taken. ,flat A plate rheometer is used to detect the elastic modulus (G') of the gel and calculate the elastic modulus loss factor, where G' loss factor is calculated by the following formula:
[0092] G' loss rate = (G' before sterilization - G' after sterilization) / G' before sterilization The parameters of the rheometer are as follows: operating gap: 1000 mm, load gap: 45000 m, operating temperature: 37° C., deformation: 1%, frequency: 0.9 Hz, operating time: 60 s. The rheological data of each gel are shown in Table 1.
[0093] [Table 1]
[0094] As can be seen from the data in Table 1, compared with the three-phase non-physically crosslinked blend gel in Comparative Example 2, the three-phase gel obtained by physical crosslinking in Example 3 has an improved elastic modulus and a certain degree of improved thermal stability, which indicates that physical crosslinking contributes to a certain degree to improving the elastic modulus of the composite gel and also improves the thermal stability of the three-phase gel to a certain degree. Comparative Example 1 is merely a physical mixture of three substances, non-crosslinked HA, PLA, and HAP, so there is no chemical bonding between the three substances and they cannot withstand the severe hydrolysis during moist heat sterilization, which results in a decrease in the elastic modulus of Comparative Example 1 after sterilization of more than 97%.
[0095] In Comparative Example 3, physical crosslinking was performed on PLA and HA, but HAP was not added, so the elastic modulus of the composite gel was lower than that of Example 3. G’ After HAP and PLA form composite microspheres, nano-HAP can be introduced into the macroscopic network structure of cross-linked hyaluronic acid with the micron-scale PLA as a carrier (the particles of cross-linked hyaluronic acid are also micron-scale), and the complexation of calcium ions with the carboxyl and hydroxyl groups in hyaluronic acid can fill the network gaps between cross-linked hyaluronic acid, thereby making the three-phase gel have a tighter network structure; at the same time, the complexation of HAP and HA can shorten the distance between the molecular chains of PLA and HA, which improves the cross-linking reaction efficiency of both, and therefore shows higher elastic modulus and stronger thermal stability.
[0096] Comparative Example 4 discloses a physical blend of nanoscale HAP and cross-linked hyaluronic acid, but does not show high elastic modulus and strong thermal stability. The reason is that in Comparative Example 4, nanoscale HAP is directly added, and compared with micron-scale cross-linked hyaluronic acid gel, the difference in physical size between the two is large. As a result, the spatial difference between the two is large, so that HAP has difficulty filling the gaps in the cross-linked hyaluronic acid gel and cannot form a denser network structure.
[0097] This also shows that by forming two-phase microspheres with HAP and PLA, and supporting HAP on a micron-scale PLA carrier, it can further form a tighter network structure with the cross-linked hyaluronic acid gel, and thus has higher elastic modulus and stronger thermal stability. Therefore, the composite gel can improve the elastic modulus and thermal stability of the three-phase gel through the mutual synergistic effect between the cross-linked hyaluronic acid and the PLA-HAP two-phase microspheres, and all three components are essential.
[0098] The elastic modulus of the three-phase composite gel obtained by chemical cross-linking in Examples 4, 7 and 8 is obviously improved, which indicates that when physical cross-linking is replaced by chemical cross-linking, the bond action strength formed by chemical cross-linking is much higher than the interaction strength of physical cross-linking, so the interaction between the three parties of cross-linked hyaluronic acid, HAP (or other nanoscale calcium salts) and PLA is further strengthened, and the elastic modulus and thermal stability of the chemically cross-linked three-phase gel are further improved compared with those of the physically cross-linked three-phase gel.
[0099] Finally, as an illustration, the above embodiments are only used to describe the technical solutions of the present invention, and are not intended to limit the same; the present invention will be described in more detail with reference to the above embodiments, but those skilled in the art should understand that the technical solutions described in the above embodiments can be modified or equivalently substituted for some or all of the technical features therein; these modifications or equivalent substitutions do not cause the essence of the corresponding technical solutions to depart from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. A composite gel obtained by crosslinking two-phase microspheres with hyaluronic acid, said two-phase microspheres being polylactic acid / inorganic material two-phase microspheres. Composite gel.
2. The crosslinking comprises crosslinking polylactic acid and hyaluronic acid in the biphasic microspheres. The composite gel of claim 1.
3. The crosslinking between the polylactic acid and the hyaluronic acid includes any one of physical electrostatic crosslinking and chemical crosslinking. The composite gel according to claim 2.
4. The inorganic material is one or more selected from calcium carbonate, calcium phosphate, and calcium tartrate; further, the calcium phosphate is preferably hydroxyapatite; and further, the inorganic material is a nano-inorganic material. The composite gel of claim 1.
5. The hyaluronic acid is crosslinked hyaluronic acid; further, the crosslinked hyaluronic acid is prepared by a crosslinking agent, the crosslinking agent being one or more selected from dialdehydes, disulfides, polyethylene glycol (PEG) crosslinkers, divinyl sulfones, diglycidyl ethers, diepoxides, and polyamines; and further, the crosslinking agent is an endogenous polyamine. The composite gel according to claim 3.
6. A method for preparing a composite gel, comprising crosslinking a biphasic microsphere with hyaluronic acid to form a composite gel, the biphasic microsphere being a polylactic acid / inorganic biphasic microsphere, and the crosslinking comprises crosslinking the polylactic acid and the hyaluronic acid in the biphasic microsphere. Method for preparing composite gel.
7. The crosslinking is a solid-phase crosslinking; and the solid-phase crosslinking includes any one of a physical electrostatic crosslinking and a chemical crosslinking. The preparation method according to claim 6.
8. The hyaluronic acid is crosslinked hyaluronic acid, and the crosslinked hyaluronic acid is prepared by a crosslinking agent, and the crosslinking agent is one or more selected from dialdehyde, disulfide, polyethylene glycol (PEG) crosslinker, divinyl sulfone, diglycidyl ether, diepoxide, and polyamine. The preparation method according to claim 7.
9. The chemical crosslinking includes amino-modifying the polylactic acid in the biphasic microspheres and then reacting the modified biphasic microspheres with hyaluronic acid to form amide bond crosslinks; the amino-modification further includes reacting the biphasic microspheres with an amine compound; and the amide bond crosslinking further includes coupling the modified biphasic microspheres with hyaluronic acid in the presence of a carbodiimide activator. The preparation method according to claim 7.
10. The amine compound includes a polyamine or a polyamino compound, Preferably, the polyamine comprises any one of an aliphatic polyamine, an aromatic polyamine, and a heteroatom polyamine; the polyamino compound comprises any one of a double-end aminated polyethylene glycol and a terminally aminated multi-arm polyethylene glycol; Further, the carbodiimide activator comprises one or more of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, 1-(3-dimethylaminopropyl)-3-ethyl-carbodiimide, 1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide, 1,3-bis[di(methoxymethyl)methyl]carbodiimide, or a salt thereof; 10. The preparation method according to claim 9.
11. The mass ratio of the biphasic microspheres to the hyaluronic acid in the chemical crosslinking is 1:0.5-20, preferably 1:1-10; Furthermore, the amount of the amine compound added is 30% to 200% of the mass of the two-phase microsphere, and the concentration range of the amine compound is 10 mg / mL to 1000 mg / mL; Furthermore, the amount of the carbodiimide activator added is 10% to 150% of the total mass of the hyaluronic acid; Furthermore, the concentration of the hyaluronic acid solution is 10 mg / mL to 100 mg / mL; Furthermore, the temperature of the amino modification reaction and the amide bond crosslinking reaction is 5° C. to 60° C., and the reaction time is 6 hours to 24 hours.
11. The preparation method according to claim 9 or 10.
12. The physical electrostatic crosslinking includes: performing surface charge modification on the biphasic microspheres to obtain modified biphasic microspheres carrying anions on the surface; mixing the modified biphasic microspheres with crosslinked hyaluronic acid having cations to generate electrostatic crosslinks; the crosslinked hyaluronic acid having cations is crosslinked with polyamine; and the surface charge modification on the biphasic microspheres includes immersing the biphasic microspheres in an alkaline buffer solution and separating the microspheres. The preparation method according to claim 7.
13. The weight ratio of the two-phase microspheres to the cross-linked hyaluronic acid in the physical electrostatic cross-linking is 1:1-50; preferably 1:1-20; Further, the alkaline buffer is an alkaline phosphate buffer; the pH range of the alkaline phosphate buffer is preferably 9.0 to 11.
0.
13. The preparation method according to claim 12.
14. Application of the composite gel according to any one of claims 1 to 5 or obtained by the preparation method according to any one of claims 6 to 13 in the manufacture of a drug carrier, a filler or a tissue repair material.
Citation Information
Patent Citations
Method for preparing nano hydroxyapatite / polylactic acid composite microspheres
CN101590388A
Mixed gel of polylactic acid microspheres and cross-linked hyaluronic acid for injection and preparation method of mixed gel
CN104258470A
Preparing method of injectable sodium hyaluronate gel containing microballoons
CN109621003A
A crosslinked amide derivative of hyaluronic acid and a method for producing the same.
JP2004511588A
Injectable sterile composition for skin
JP2016507592A
